EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson’s Disease Research

Tiffany Jong, Alexandra Gehrlein, Ellen Sidransky, Ravi Jagasia, Yu Chen

Journal of Parkinson’s Disease · 2024

DOI: 10.3233/jpd-230295 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Parkinson’s Disease, 2024. Verfasst von Tiffany Jong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mutations in GBA1, which encodes the lysosome enzyme β-glucocerebrosidase (also referred to as acid β-glucosidase or GCase), are the most common genetic risk factor for Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). Evidence also suggests that loss of GCase activity is implicated in PD without GBA1 mutations. Consequently, therapies targeting GCase are actively being pursued as potential strategies to modify the progression of PD and related synucleinopathies. Despite this significant interest in GCase as a therapeutic target, the lack of well-characterized GCase antibodies continues to impede progress in the development of GCase-targeted therapies.

Objective

This study aims to independently evaluate human GCase (hGCase) antibodies to provide recommendations for western blot, immunofluorescence, immunoprecipitation, and AlphaLISA (Amplified Luminescent Proximity Homogeneous Assay) assays.

Methods

Two mouse monoclonal antibodies, hGCase-1/17 and hGCase-1/23, were raised against hGCase using imiglucerase, the recombinant enzyme developed to treat patients, as the antigen. These novel antibodies, alongside commonly used antibodies in the field, underwent evaluation in a variety of assays.

Results

The characterization of hGCase-1/17 and hGCase-1/23 using genetic models including GBA1 loss-of-function human neuroglioma H4 line and neurons differentiated from human embryonic stem cells revealed their remarkable specificity and potency in immunofluorescence and immunoprecipitation assays. Furthermore, a hGCase AlphaLISA assay with excellent sensitivity, a broad dynamic range, and suitability for high throughput applications was developed using hGCase-1/17 and hGCase-1/23, which enabled a sandwich assay configuration.

Conclusions

The hGCase immunofluorescence, immunoprecipitation, and AlphaLISA assays utilizing hGCase-1/17 and hGCase-1/23 will not only facilitate improved investigations of hGCase biology, but can also serve as tools to assess the distribution and effectiveness of GCase-targeted therapies for PD and related synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseSynucleinopathiesAnimalsMiceHumansGlucosylceramidaseNeuronsCell DifferentiationMutationalpha-SynucleinLysosomes

Stichwörter der Autor:innen

Gaucher diseaseParkinson’s diseaseglucocerebrosidasemonoclonal antibody

Substanzen

Glucosylceramidasealpha-Synuclein

Autor:innen und Institutionen

  • Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.
  • Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.

Zitieren

APA

Jong, T., Gehrlein, A., Sidransky, E., Jagasia, R., & Chen, Y. (2024). Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson’s Disease Research. Journal of Parkinson’s Disease. https://doi.org/10.3233/jpd-230295

Vancouver

Jong T, Gehrlein A, Sidransky E, Jagasia R, Chen Y. Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson’s Disease Research. Journal of Parkinson’s Disease. 2024. doi:10.3233/jpd-230295

BibTeX
@article{Jong2024,
  author = {Jong, Tiffany and Gehrlein, Alexandra and Sidransky, Ellen and Jagasia, Ravi and Chen, Yu},
  title = {Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson’s Disease Research},
  journal = {Journal of Parkinson’s Disease},
  year = {2024},
  doi = {10.3233/jpd-230295}
}
Kostenlos starten →